What critical risk arises when taking elderberry concurrently with immunosuppressant medications, such as those used post-organ transplant?
Counteracting the intended effects of the drugs, potentially leading to treatment failure or organ rejection.
Immunosuppressant drugs are vital for patients who have received organ transplants or those whose severe autoimmune conditions require suppression of immune overreaction to self-tissue. These powerful medications function by dampening the immune system. Because elderberry may enhance immune system activity, taking it alongside immunosuppressants creates a direct antagonism. The stimulating effect of the herb can work against the therapeutic goal of the medication, raising the significant risk that the body might reject a transplanted organ or that treatment for the underlying autoimmune disease will fail due to insufficient immune suppression.
